Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Disease evolution and outcomes in familial AML with germline CEBPA mutations

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clonal hematopoiesis in elderly twins: concordance, discordance and mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Myelodysplastic syndrome patient-derived xenografts: from no options to many

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. ERG Controls B Cell Development by Promoting Igh V-to-DJ Recombination

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Kiran Tawana
  • Jun Wang
  • Aline Renneville
  • Csaba Bödör
  • Robert Hills
  • Chey Loveday
  • Aleksandar Savic
  • Frederik W Van Delft
  • Jennifer Treleaven
  • Panayiotis Georgiades
  • Elizabeth Uglow
  • Norio Asou
  • Naokuni Uike
  • Maruša Debeljak
  • Janez Jazbec
  • Philip Ancliff
  • Rosemary Gale
  • Xavier Thomas
  • Valerie Mialou
  • Konstanze Döhner
  • Lars Bullinger
  • Beatrice Mueller
  • Thomas Pabst
  • Matthias Stelljes
  • Brigitte Schlegelberger
  • Eva Wozniak
  • Sameena Iqbal
  • Jessica Okosun
  • Shamzah Araf
  • Anne-Katrine Frank
  • Felicia B Lauridsen
  • Bo Porse
  • Claus Nerlov
  • Carolyn Owen
  • Inderjeet Dokal
  • John Gribben
  • Matthew Smith
  • Claude Preudhomme
  • Claude Chelala
  • Jamie Cavenagh
  • Jude Fitzgibbon
Vis graf over relationer

To date, in-depth molecular investigation of familial leukemia has been limited by the rarity of recognized cases. This study comprehensively examines the genetic events initiating leukemia and details the clinical progression of disease across multiple families harboring germline CEBPA mutations. Clinical data were collected from 10 CEBPA-mutated families, representing 24 members with AML. Whole-exome (WES) and deep sequencing were performed to genetically profile tumors and define patterns of clonal evolution. Germline CEBPA mutations clustered within the N-terminal and were highly penetrant, with AML presenting at a median age of 24.5yrs (1.75-46yrs). In all diagnostic tumors tested (n=18), double CEBPA mutations (CEBPAdm) were detected, with acquired (somatic) mutations preferentially targeting the C-terminal. Somatic CEBPA mutations were found to be unstable throughout the disease course, with different mutations identified at disease recurrence. Deep sequencing of diagnostic and relapse paired samples confirmed that relapse-associated CEBPA mutations were absent at diagnosis, suggesting recurrence was triggered by novel, independent clones. Integrated WES and deep sequencing subsequently revealed an entirely new complement of mutations at relapse, verifying the presentation of a de novo leukemic episode. The cumulative incidence of relapse in familial AML was 56% at 10yrs (n=11) and 3 patients experienced ≥3 disease episodes over a period of 17-20yrs. Durable responses to secondary therapies were observed, with prolonged median survival post relapse (8yrs) and long term overall survival (10yr OS, 67%). Our data reveal that familial CEBPA-mutated AML exhibits a unique model of disease progression, associated with favorable long term outcomes.

OriginalsprogEngelsk
TidsskriftBlood
Vol/bind126
Udgave nummer10
Sider (fra-til)1214-1223
ISSN0006-4971
DOI
StatusUdgivet - 3 sep. 2015

ID: 45569303